ClearPoint Neuro, Inc.
CLPT· Nasdaq
Filed Nov 14, 2012 · 10-Q · -320 days after period end · 0001437749-12-011723
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $927.46K | $1.13M | $1.15M |
| Net Income | -$3.19M | -$2.76M | -$2.14M |
| EPS Diluted | -$0.05 | -$0.06 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 14, 2012 · -320 d after period end